Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00373958 · ClinicalTrials.gov registry record · Phase 3
Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine
A Phase 3 study of Vaccines, Pneumococcal, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 666
- Enrollment target
- 20
- Study locations
NCT00373958 is a Phase 3 study of Vaccines, Pneumococcal that has completed, run by Pfizer. The registered enrollment target is 666 participants. The trial reports 20 study locations across 10 states.
The verdict
NCT00373958, a Phase 3 study of Vaccines, Pneumococcal, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 666 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of the 13-valent pneumococcal vaccine (13vPnC) compare to the 7-valent pneumococcal vaccine (7vPnC) and to compare the immune response to concomitant vaccines administered with 13vPnC and 7vPnC.
Conditions Studied
Interventions
- BIOLOGICAL 13 valent pneumococcal conjugate vaccine
- BIOLOGICAL 7vPnc pneumococcal conjugate vaccine
Study Locations (20)
California
- - Downey
- - Fontana
- - Loma Linda
- - Paramount
- - Riverside
Arkansas
- - Fayetteville
- - Jonesboro
- - Little Rock
Kentucky
- - Bardstown
- - Louisville
- - Louisville
Georgia
- - Marietta
- - Woodstock
Illinois
- - Chicago
- - Park Ridge
Colorado
- - Centennial
Connecticut
- - Norwich
Florida
- - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 666 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00373958
The ClinicalTrials.gov registry entry for NCT00373958 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 666 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vaccines, Pneumococcal appearing as the primary indexed condition, and to 2 interventions - of which 13 valent pneumococcal conjugate vaccine is the first listed.
NCT00373958 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Arkansas, Kentucky.
Frequently Asked Questions
What is clinical trial NCT00373958 about?
NCT00373958 is a clinical study titled "Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine". The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of the 13-valent pneumococcal vaccine (13vPnC) compare to the 7-valent pneumococcal vaccine (7vPnC) and to compare the immune response to concomitant vaccines administered with 13vPnC and 7vPnC.
What is the current status of trial NCT00373958?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 666 participants. The study started on 2006-09. Estimated completion is 2008-06.
What conditions does trial NCT00373958 study?
This clinical trial studies the following conditions: Vaccines, Pneumococcal.
What interventions are being tested in trial NCT00373958?
The interventions under investigation include: 13 valent pneumococcal conjugate vaccine (BIOLOGICAL), 7vPnc pneumococcal conjugate vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00373958?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00373958 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccines, Pneumococcal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.